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Bacteriocins related to colicin M, acting via cleavage of the cell wall precursor lipid
II, have been characterized in γ- and β-proteobacteria. Depending on the species,
immunity is provided by either an inner membrane-anchored periplasmic protein or by
an integral membrane protein. In Pseudomonas however, the immunity partner of colicin
M-like bacteriocins remains unknown. Based on an in silico analysis in pseudomonad
genomes, we here identify a gene encoding a putative immunity partner that represents
a novel type of integral membrane protein (PmiA, Pseudomonas colicin M-like immunity
type A). By heterologous expression of pmiA genes in susceptible strains, we show
that immunity to colicin M-like bacteriocins is indeed provided by the cognate PmiA.
Sequence homology among PmiA proteins is essentially absent, except for a short
motif with a conserved periplasm-exposed aspartate residue. However, PmiA’s protective
function is not abolished by changing this acidic residue to the uncharged alanine.
Immunity by PmiAs appears promiscuous to the extent that PmiA homologs from a
clade sharing <40% pairwise amino acid identity, equally provide protection against
the bacteriocin linked to the original PmiA. This study shows that multiple immunity
factors have evolved independently to silence lipid II-targeting enzymatic bacteriocins.
Their relaxed bacteriocin immunization capacity contrasts to the strict specificity of
immunity proteins shielding the enzymatic domain of nuclease bacteriocins. The nature
of associated immune functions needs consideration when using such natural protein
antibiotics or designing novel variants.
Keywords: colicin M, PmiA, PmiB, pyocin, peptidoglycan, lipid II
INTRODUCTION
Antibacterial proteins are currently subject of renewed interest in the search for antimicrobials with
novel modes of action. As yet poorly explored potential sources of such alternative protein-based
antibiotics include lytic bacteriophages (Gerstmans et al., 2016) and bacteriocinogenic strains
(Schulz et al., 2015). Bacteriocins are key mediators of intra-species competition between bacteria
and combine high specificity with single-hit killing potency. Prominent bacteriocin producers
that target human and plant pathogenic Gram-negative bacteria are found among enterobacteria
(Cascales et al., 2007; Holt et al., 2013; Grinter et al., 2014; Schulz et al., 2015) and pseudomonads
(Ghequire and De Mot, 2014).
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Pseudomonas bacteriocins are very diverse with respect to
structure and mode of action. R-type and F-type tailocins
are multiprotein complexes that are evolutionary related to
bacteriophage tails (Ghequire and De Mot, 2015a; Ghequire
et al., 2015; Hockett et al., 2015). Lectin-like bacteriocins are
constituted of a tandem of monocot mannose-binding lectin
domains, and kill target cells via an unknown mechanism
(Ghequire et al., 2013, 2014; McCaughey et al., 2014). S-
type bacteriocins are multi-domain toxins with a modular
structure similar to colicins, the bacteriocins from Escherichia
coli (Cascales et al., 2007; Ghequire and De Mot, 2014;
Dingemans et al., 2016; McCaughey et al., 2016). Self-
inhibition of Pseudomonas aeruginosa strains producing a S-
type bacteriocin (S pyocin) is circumvented by an immunity
protein that transiently impedes the bacteriocin’s toxic function.
This immunity complement is co-expressed with the bacteriocin,
and is typically encoded downstream of the pyocin gene, on
the same or opposite strand. In the case of S-type bacteriocins
with nuclease activity, bacteriocins are secreted as high-affinity
bacteriocin-immunity protein complexes (Joshi et al., 2015).
Pseudomonas colicinM-like bacteriocins (PseuMs) host a lipid II-
cleaving domain, homologous to the catalytic domain of colicin
M (ColM; Barreteau et al., 2009, 2012; Grinter et al., 2012b).
However, in contrast to S pyocin-immunity complexes, it is not
clear how PseuM producers protect themselves. Inspection of
their pseuM genomic context did not reveal homologs of cmi,
the cognate immunity partner for ColM in E. coli, nor were such
homologs detected elsewhere in their genomes (Barreteau et al.,
2009).
In E. coli, the cmi gene is located downstream of the
bacteriocin gene on the opposite strand (Olschläger et al., 1984;
Olschläger and Braun, 1987). Located in the periplasm, Cmi
is anchored to the inner membrane by an amino-terminal
hydrophobic α-helix, assisting in secretion but not being cleaved
off. There, Cmi transiently impedes colicin M’s activity during
secretion and inactivates imported ColM (Olschläger and Braun,
1987; Olschläger et al., 1991; Gross and Braun, 1996). The crystal
structure of Cmi revealed the presence of four α-helices and
four β-strands, and is exemplary of a YebF fold (Gérard et al.,
2011; Usón et al., 2012). In Pectobacterium a cmi-like gene is
located downstream and opposite of the pectocin M gene, but
its protective functionality remains to be demonstrated (Grinter
et al., 2012a). In most strains of Burkholderia producing colicin
M-like burkhocins, immunity is mediated by bmiB genes that
give rise to proteins with a small size and predicted topology
similar to Cmi (Ghequire and De Mot, 2015b). However, the
amino acid sequence of the periplasmic moiety of BmiB is
unrelated to Cmi and lacks the characteristic YebF domain.
Fewer strains carry a second type of burkhocin immunity
gene (bmiA) that encodes a small integral membrane protein
comprising three transmembrane helices.
In this study we investigated the genomic context of
pseuM genes, in search for candidate immunity partners. We
demonstrate that a gene downstream of pseuM provides cognate
immunity. Apart from sharing a common membrane topology
reminiscent of BmiA proteins, the encoded proteins display very
poor sequence conservation across PseuM-bacteriocinogenic
pseudomonads. The possible role of a short semi-conservedmotif
in these proteins is explored, as well as the capability of PmiA
proteins to immunize targeted cells in an (a)specific way.
MATERIALS AND METHODS
Genome Searches and Phylogenetic
Analysis
PseuM bacteriocin genes in Pseudomonas genomes were
identified by homology searches using the National Center
for Biotechnology (NCBI) non-redundant database. The Pfam
Colicin_M module PF14859 was used as a query. Genes
downstream of unique pseuM bacteriocin gene products were
selected for further analysis. Multiple sequence alignments
were generated with MUSCLE and phylogenetic reconstructions
were carried out with PhyML (1000 bootstrap replicates),
implemented in Geneious v7.1.7. The JTT substitution model
(Jones et al., 1992) was used for studying the evolution of
a large number of amino acid sequences. Amino-terminal
signal sequences were predicted by PRED-TAT (http://www.
compgen.org/tools/PRED-TAT) and TOPCONS (http://topcons.
cbr.su.se/). Transmembrane regions and topology were predicted
by TMHMM (http://www.cbs.dtu.dk/services/TMHMM/), and
TOPCONS.
Bacterial Strains and Media
Strains used in this study are listed in Table S1. E. coli was
grown in LB (MP Biomedicals) at 37◦C, whereas Pseudomonas
strains were grown with shaking at 200 rpm in Trypticase Soy
Broth (TSB, BD Biosciences) and Casamino Acids Medium
(CAA, BD Biosciences) at 30◦C, except for P. aeruginosa
that was grown at 37◦C. Growth media were supplemented
with agar (1.5%, Invitrogen), filter-sterilized isopropyl-β-
D-thiogalactopyranoside (IPTG, 20 µg/ml, ForMedium),
kanamycin (50 µg/ml, Sigma-Aldrich), or tetracycline (15–150
µg/ml, Sigma-Aldrich) when required. Strains were kept on plate
at 4◦C, or at−80◦C in glycerol (25% v/v, Sigma-Aldrich).
DNA Methods and Construction of
Plasmids
Genomic DNA was collected with the Puregene Yeast/Bact. Kit B
(Qiagen). Synthetic genes and primers were obtained from IDT
DNA. Genes encoding bacteriocins (ERS445055_00256 from
P. aeruginosa NCTC10332, PFLQ8_1129 from Pseudomonas
fluorescens Q8r1-96 (Landa et al., 2003) and PSPTO_0572
from Pseudomonas syringae pv. tomato DC3000) and putative
immunity proteins, encoded downstream, were amplified by
polymerase chain reaction (PCR) with Q5 polymerase (New
England Biolabs), with a T100TM Thermal cycler (Bio-Rad). Q5
polymerase was used according to the supplier’s specifications.
All primers are listed in Table S2. PCR fragments were purified
with the Genelute PCR clean-up kit (Sigma-Aldrich), and double
digested with NcoI/XhoI (1 h at 37◦C, New England Biolabs)
in the case of the bacteriocin genes, and with PstI/XbaI (1 h
at 37◦C, New England Biolabs) in the case of the putative
immunity genes. The immunity gene amplicon of P. aeruginosa
NCTC10332 was digested with PstI/EcoRI (1 h at 37◦C, New
Frontiers in Microbiology | www.frontiersin.org 2 January 2017 | Volume 8 | Article 93
Ghequire et al. Immunity to Pseudomonas Colicin M-like Bacteriocins
England Biolabs). Purified bacteriocin genes were ligated with
T4 DNA ligase (1 h at 37◦C, Invitrogen) in pET28a(+) and
putative immunity genes in shuttle vector pJB3Tc20. Ligation
products were transformed to E. coli DH5α via heat shock.
Standard methods were used for the preparation of competent
E. coli cells and heat shock transformation of E. coli (Green and
Sambrook, 2012). Transformants were initially verified for the
presence of insert by PCR with Taq polymerase (New England
Biolabs), using conditions as specified by the supplier. Plasmids
were subsequently harvested with the Genelute HP plasmid
miniprep kit (Sigma-Aldrich) and sequence confirmed for the
presence of correct insert (GATC Biotech, Constance, Germany).
Cloned immunity genes encompassed a 19-bp upstream region
containing the predicted ribosome binding sites. Resulting
plasmids are summarized in Table S1. The pET28a constructs
were transformed to E. coli BL21/DE3 via heat shock, and
pJB3Tc20 constructs electroporated to PseuM-susceptible
Pseudomonas strains, and selected on the proper medium.
Immunity genes encoding a mutation in a conserved aspartate
residue were constructed via splicing by overlap extension, using
pCMPG6251 (encoding the putative immunity complement of
PseuMDC3000), pCMPG6252 (complement of PseuMNCTC10332),
and pCMPG6269 (complement of PseuMQ8r1-96) as a
template.
Expression and Purification of
Recombinant Bacteriocins
Recombinant carboxy-terminally His-tagged bacteriocins were
generated in E. coli BL21(DE3) carrying pCMPG6248 (encoding
PseuM from P. syringae DC3000), pCMPG6250 (encoding
PseuM from P. aeruginosa NCTC10332) or pCMPG6271
(encoding PseuM from P. fluorescens Q8r1-96). Five milliliters
of overnight cultures were transferred to 500 ml LB Erlenmeyer
flasks and incubated at 37◦C until OD600 reached 0.7. After,
cultures were cooled and supplemented with IPTG (1 mM final
concentration) and incubated at 20◦C for 16 h. Next day, cells
were harvested via centrifugation (20 min, 5000 g; Beckman
X-15R) and frozen overnight (−20◦C). Subsequently, the cell
pellets were thawed, resuspended in lysis buffer (5ml/g cell
pellet; 300 mM NaCl, 50 mM NaH2PO4, 10 mM imidazole,
pH 8.0) and sonicated (amplitude 20%, 10 cycles of 30 s
on/off; Branson Digital Sonifier). Samples were treated with
nuclease (0.01 U/µl, 37◦C, 1 h; Invitrogen), remaining debris
and insoluble proteins removed via centrifugation (30 min,
10000 g), and supernatants filtered (0.20 µm, Sarstedt). Soluble
fractions containing the recombinant proteins were loaded on
a 5-ml HisTrap HP column (GE Healthcare) and purified
by nickel affinity chromatography with an Äkta Purifier (GE
Healthcare). Matrix-bound proteins were eluted with a linear
gradient of imidazole (10–500 mM) in lysis buffer. Fractions
eluted at high imidazole concentrations were validated for the
presence of recombinant protein, pooled and dialyzed to Tris
buffer (50 mM, NaCl 200 mM, pH 7.5). Concentration of
purified PseuMs was determined with a Genesys 10S UV-Vis
Spectrophotometer (Thermo Scientific). Calculated extinction
coefficients were 30035 mol/L−1 cm−1, 73340 mol/L−1 cm−1,
and 32890 mol/L−1 cm−1 for the His-tagged PseuM bacteriocins
from strains DC3000, NCTC10332, and Q8r1-96, respectively.
Bacteriocin Assay
Bacteriocin activity was determined via spot assay. Filter-
sterilized 20-µl volumes of purified recombinant proteins
(1mg/ml) were spotted onto bacterial cell lawns. After, samples
were air-dried and incubated overnight. Dialysis buffer was used
as a negative control. Following day, petri dishes were scored for
zones lacking bacterial growth (halos).
Nucleotide Accession Number
GenBank accession number of the nucleotide sequence of the
pseuM-pmiA pair from P. putida RW10S2 (Rokni-Zadeh et al.,
2012) is KX086738.
RESULTS
In silico Search for Candidate Genes
Providing Immunity to Pseudomonas
Colicin M-like Bacteriocins
Based on the genetic architecture of modular bacteriocins in
Gram-negatives, it is anticipated that bacteriocin immunity genes
are likely to be found in proximity of their corresponding toxin
genes. By scrutiny of their genomic contexts we observed that
the characterized Pseudomonas colicin M-like bacteriocin genes,
as well as several other predicted PseuM-encoding genes (Figure
S1A), are consistently followed on the same DNA strand—at
variable distances but within <200 nucleotides—by an open
reading frame, but infrequently annotated as a coding region
(Table S3). Typically, G+C content of these regions (∼1.8 kb)
is significantly lower (41–52%) than the Pseudomonas genome
averages (P. aeruginosa: 66.2%, 1647 genomes; P. fluorescens:
60.2%, 92 genomes; P. syringae: 58.7%, 153 genomes). None
of the deduced protein sequences contains the YebF domain
signature (Pfam PF13995) as found in Cmi and the putative
pectocin M immunity proteins.
In 14 Pseudomonas strains, mostly P. syringae pathovars, the
encoded proteins (encompassing eight unique but very similar
sequences of ∼100 AAs) show only borderline homology with
the burkhocin-associated BmiB immunity proteins (12–24%
pairwise AA identity). However, these pseudomonad proteins,
designated PmiBs, share with BmiBs two perfectly conserved
cysteines (Figure S2). The PmiB and BmiB proteins are predicted
to be translocated to the periplasm, albeit this appears to be
achieved in different ways: instead of the BmiB amino-terminal
membrane-anchoring segment or Sec-dependent cleavable signal
sequence, a cleavable lipoprotein signal sequence typifies PmiB.
This common feature is reflected in the phylogeny of ColM
domains that reveals a well-separated clade harboring both the
burkhocins and this small subset of PseuM proteins (Figure S1B).
The majority of PseuM-derived ColM domains constitutes
a separate clade of much more diversified sequences that are
evolutionarily related to the corresponding domains in colicin
M and colicin M domain-containing pectocins (Figure 1A,
Figure S1B). In this second subset of PseuM-bacteriocinogenic
strains the bacteriocin gene is linked with a gene encoding
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a protein unrelated to PmiB (∼137 AAs; Figure S3). This
protein family, designated PmiA, features four transmembrane
helices, of which the first is predicted to represent a candidate
Sec- or Tat-dependent cleavable signal sequence (Figure 2). The
inferred topology, with two moieties facing the periplasm and
two stretches (including the carboxy-terminus) residing in the
cytoplasm, is reminiscent of the one adopted by BmiA proteins,
albeit the latter lack an equivalent secretory signal sequence
(Ghequire and De Mot, 2015b). No sequence homology can
be detected between BmiAs and PmiAs however. Notably, four
phytopathogenic strains of the P. syringae group each carry two
unlinked PseuM-encoding paralogues, one from each PseuM
clade and clustered with, respectively, a pmiA and pmiB gene. The
low level of sequence identity between these bacteriocins (∼24%)
combined with the different nature of the respective candidate
immunity proteins argues against a common ancestry and favors
their independent acquisition.
In different strains, the pseuM-pmiA gene pair has been
recruited to diverse genomic locations. Several of these regions
correspond to mobile elements. In P. aeruginosa, the gene couple
generally occurs on ExoU island A, as has previously been noted
for the pseuM of P. aeruginosa JJ692 (Barreteau et al., 2009).
FIGURE 1 | Maximum likelihood phylogenetic trees of ColM domains from pmiA-associated PseuMs and from related γ-proteobacterial bacteriocins
(A), and of associated Pseudomonas PmiA immunity proteins (B). Characterized PseuM bacteriocins and cognate PmiAs are colored blue, colicin M (ColM) from E.
coli is shown in red, and colicin M domain-containing pectocins (PecM1 and PecM2) in pink. PmiAs that were studied for promiscuity are shown in teal. The scale bars
represent 0.3 (A) and 0.8 (B) substitutions per site. Bootstrap values (percentages of 1000 replicates) higher than 50 are shown at the branches. (A) For highly
homologous colicin M domains (>95% pairwise AA identity), only one representative was included for phylogenetic tree construction. Species abbreviations: Ecoli,
Escherichia coli; Paer, Pseudomonas aeruginosa; Pbra, Pseudomonas brassicacearum; Pbre, Pseudomonas brenneri; Pcar, Pectobacterium carotovorum; Pflu,
Pseudomonas fluorescens; Pput, Pseudomonas putida; Psp, Pseudomonas sp.; Psyr, Pseudomonas syringae; Psyr cory, P. syringae pv. coryli; Psyr tom, P. syringae
pv. tomato; Ptol, Pseudomonas tolaasii.
FIGURE 2 | Membrane topology model of integral membrane proteins PmiA and BmiA, and membrane-anchored proteins Cmi, PmiB, and BmiB,
providing immunity to the activity of the ColM domain. PmiA from Pseudomonas has four predicted transmembrane helices, the first of which may represent a
Sec- or Tat-dependent signal sequence (box). BmiA from Burkholderia carries three transmembrane helices. Cmi has a periplasmic YebF domain and is anchored in
the inner membrane (IM) via an amino-terminal helix. PmiB and BmiB are equally anchored in the IM, and carry homologous periplasmic domains. “N” depicts the
amino-terminus.
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In some strains from the P. syringae group, such as isolates
642 and LMG 2367, pseuM-pmiA combinations appear as a
cargo gene couple in a trpE/trpG-integrated Rp4 tailocin cluster
(Hockett et al., 2015). In other P. syringae pathovar strains,
such as DC3000 and ICMP 3923, the cargo is equally part of a
Rp4-type sequence, although incomplete and apparently linked
with diverged sequences. In some P. fluorescens group strains,
such as Pseudomonas brassicacearumNFM421 and 51MFVCI2.1,
and P. fluorescens Q8r1-96, the gene pair has been recruited by
a Rp4 tailocin cluster as well, sandwiched between mutS and
cinA (Ghequire et al., 2015; Hockett et al., 2015). For other
strains, such as P. veronii R4, Pseudomonas sp. BRG-100 and
Pseudomonas tolaasii 6264, regions flanking the pseuM-pmiA
couples correspond to an unassigned prophage. The presence of
bacteriocin cargo genes on mobile elements has previously been
noted for lectin-like bacteriocins embedded in Pseudomonas Rp2
tailocin clusters (Ghequire et al., 2015).
Some Pseudomonas strains carry a pmiA gene that is not
linked to a cognate pseuM gene. The presence of pseuM
remnant sequences upstream of such a pmiA orphan indicates
that these strains may represent so-called cheaters that have
lost the capacity of bacteriocin production but retain the
associated immune function (Figure 3). For instance, in the
type strain Pseudomonas lundensis (DSM 6252; De Jonghe
et al., 2011) a frameshift impairs functionality of a pseuM
gene that has remained intact in Pseudomonas sp. AU9518.
From the equivalent genomic region of type strain Pseudomonas
weihenstephanensis (DSM 291166; von Neubeck et al., 2016) and
some related strains (TAD18; TAA207 and DSM 28140, not
included in Figure 3), most of the 3′ region of a pseuM gene has
been deleted, while their pmiA genes are well-conserved (>92%
AA identity). No obvious pseuM sequences remain adjacent to
the pmiA gene of Arabidopsis isolate Pseudomonas sp. Leaf48
(Bai et al., 2015), that is flanked by prophage genes.
PmiA Proteins are Cognate PseuM
Immunity Partners
Previously described PseuM bacteriocins from P. aeruginosa
NCTC10332 (PaeM), P. fluorescens Q8r1-96 (PflM), and
P. syringae pv. tomato DC3000 (PsyM), each with a downstream
pmiA gene (as identified by in silico analysis described in Section
In silico Search for Candidate Genes Providing Immunity to
Pseudomonas Colicin M-like Bacteriocins), were recombinantly
expressed in E. coli and the His-tagged proteins purified by
Ni-NTA affinity chromatography. Strain NCTC10332 encodes a
PseuM bacteriocin that shares 90% AA identity with PaeM from
P. aeruginosa JJ692 (Barreteau et al., 2009). Antibacterial activity
of the recombinant proteins was challenged via spot-on-lawn
assay against a panel of Pseudomonas strains, and strains with
a clear halo susceptibility phenotype were selected for further
FIGURE 3 | Genomic context of orphan pmiA genes in pseudomonads. Syntenic regions carrying a pmiA homolog associated with a full-length
PseuM-encoding gene are shown for Pseudomonas sp. strains AU9518 (A), GM55 (B), NFACC04-2 (C), and NFACC51 (D). Synteny between these predicted
bacteriocin producers and phylogenetically related cheaters lacking a (functional) bacteriocin gene is highlighted by upstream and downstream ORFs (arrows) shown
in the same color. The gray-colored ORFs (D) reflect a local lack of synteny. Remnants of the respective pseuM genes are represented by white-colored rounded
shapes corresponding to a frameshifted pseuM (position marked by a dotted vertical line) or a truncated residual N- or C-terminal fragment. For Pseudomonas strains
ERGS4:02 (E) and Leaf48 (F), no strain with a closely related pmiA homolog and syntenic flanking region could be identified. Species abbreviations: Pfre,
Pseudomonas frederikbergensis; Plun, Pseudomonas lundensis; Pwei, Pseudomonas weihenstephanensis. Other abbreviations are as in Figure 1.
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experiments. Such indicator strains identified for PaeM, PflM,
and PsyM were P. aeruginosa CPHL12447, P. fluorescens F113,
and P. syringae pv. lachrymans LMG 5456 (Grinter et al., 2012b),
respectively.
Next, the putative immunity genes from strains NCTC10332,
Q8r1-96 and DC3000 were cloned in shuttle vector pJB3Tc20,
and introduced in the corresponding PseuM-susceptible strains.
Transformants were tested for altered PseuM sensitivity, using
strains carrying empty vectors as negative controls (Table 1).
When equipped with the cognate pmiA, transformants became
fully insensitive to the respective bacteriocin (tested at 1 mg/ml
by spot assay). When indicator strains were provided with
either of the other two immunity genes, no diminished PseuM
inhibition was observed. Together this indicates that PmiAs are
cognate immunity partners of the bacteriocins they are associated
with. Purified membrane fragments with the gene product of
pmiADC3000 were analyzed via Maldi-MSMS (Poetsch et al.,
2008), but no peptide fragments assignable to the PmiA of
interest could be retrieved (data not shown).
Since colicin M and colicin M-like bacteriocins domains exert
their action in the periplasm, it is plausible that (at least part
of) the periplasm-exposed moieties of PmiA proteins participate
in the immunity function, directly or indirectly impeding the
catalytic function of the ColM domain. Conserved residues in the
immunity module may be critical in providing such property. In
the mature PmiA proteins, a short well-conserved stretch with
consensus motif D[T/S]XGXP precedes the second predicted
transmembrane segment (Figure 4, Figure S3). No obvious
sequence conservation among PmiA proteins can be detected
for the shorter second periplasm-exposed loop. To further
scrutinize the possible role of the first periplasmic stretch, the
conserved Asp residue wasmutated to Ala in the PmiAs of strains
NCTC10332, Q8r1-96 and DC3000. Upon introduction of the
PmiA variants in the respective indicator strains, the immunity
phenotype to the respective PseuMs was evaluated. Halos were
absent for all three indicator strains after bacteriocin spotting,
showing the same phenotype as caused by the native immunity
gene products (Table 1). This suggests that the conserved Asp
residue is not instrumental to PmiA’s immunity function.
Immune Promiscuity among
Sequence-Diverged PmiAs
Noteworthy, sequence divergence of the PseuM-PmiA toxin-
immunity pairs seems to be most pronounced among strains
belonging to the P. fluorescens group. In contrast, for P. syringae
TABLE 1 | Heterologous expression of pmiA genes in PseuM-susceptible strains.
Indicator strain PmiA immunity protein PseuM bacteriocin
Species Gene product PaeM
P. aeruginosa
NCTC10332
PflM
P. fluorescens
Q8r1-96
PsyM
P. syringae pv. tomato
DC3000
P. aeruginosa CPHL12447 P. aeruginosa PmiANCTC10332 −
PmiA*NCTC10332 −
P. fluorescens PmiAQ8r1-96 +
P. syringae pv. tomato PmiADC3000 +
NA Control +
P. fluorescens F113 P. aeruginosa PmiANCTC10332 +
P. brassicacearum PmiADF41 −
P. fluorescens PmiAQ8r1-96 −
PmiA*Q8r1-96 −
PmiAAU2390 +
PmiAPf29Arp −
P. syringae pv. syringae PmiADC3000 +
Pseudomonas sp. PmiA5 T
PmiAGM21 +
PmiAPf153 −
NA Control +
P. syringae LMG 5456 P. aeruginosa PmiANCTC10332 +
P. syringae pv. tomato PmiADC3000 −
PmiA*DC3000 −
NA Control +
Indicator strains were transformed with shuttle vector pJB3Tc20 (control, without insert) or with pJB3Tc20-derived plasmids equipped with different pmiA genes, and tested for (altered)
susceptibility to their respective PseuM via bacteriocin spot assay. +, sensitive; −, insensitive; T, turbid halo. The species used as source of immunity protein are specified with the
respective strain names indicated as PmiA subscript (NA, not applicable). Asterisks define mutated immunity proteins (Asp to Ala). Strain LMG 5456 carrying a plasmid equipped with
pmiAQ8r1−96 could not be obtained.
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FIGURE 4 | Multiple sequence alignment of the semi-conserved stretch
in PmiA proteins, predicted to be oriented toward the periplasmic
space. Pseudomonas species abbreviations are as in Figure 1. Gray shading
reflects the degree of conservation. The conserved Asp residue that was
mutated is boxed in green.
pathovar isolates, high conservation of the ColM domain (at least
94% pairwise AA identity; Figures S1A,B) is reflected in well-
conserved immunity proteins (at least 84% pairwise AA identity).
Previously, it was demonstrated that immunity proteins sharing
high homology may provide pyocin-silencing functionality of
another partner (Dingemans et al., 2016).
To examine to what extent sequence divergence limits
the immune function, PmiA homologs from the cluster with
P. fluorescens Q8r1-96 were selected (P. brassicacearum DF41,
P. fluorescens Pf29Arp, and Pseudomonas sp. Pf153), as well
as some more distant PmiAs (Pseudomonas sp. strains 5 and
GM21, P. fluorescens AU2390; Figure 1B). The PmiAs from the
Q8r1-96 cluster share 36–40% AA identity with PmiAQ8r1-96.
This level of sequence conservation stems mainly from the
periplasm-exposed regions as well as the transmembrane helices,
whereas the amino-terminal signal sequence/transmembrane
helix and the cytoplasm-exposed stretches exhibit extensive
sequence divergence. By comparison, the ColM domains of the
PseuMs of strains DF41, Pf29Arp and Pf153, display considerably
higher sequence conservation (∼69% AA identity) with PflM.
Pairwise identity with the more distant PmiAs ranges from 18
to 31%, corresponding with more diversified ColM domains
(35–46% AA identity with PflM).
These six pmiA genes were cloned in pJB3Tc20 and introduced
in P. fluorescens F113, and tested for their capacity to protect
from PflM activity, using empty vector and the native pmiAQ8r196
immunity gene as controls for susceptibility and immunity,
respectively (Table 1). Despite only moderate pairwise identities
to PmiAQ8r1-96, PmiADF41, PmiAPf153, and PmiAPf29Arp provided
full cross-immunity to PflM. The more distantly related PmiAs
from strains AU2390 and GM21 (with 30.9 and 23.4% AA
identity, respectively) could not immunize cells against the
bacteriocin, resulting in a similar phenotype as the PmiAs from
P. aeruginosa NCTC10332 and P. syringae DC3000, and the
control. Despite barely showing homology with PmiAQ8r1-96
(18.4% AA identity), PmiA from Pseudomonas sp. 5 conferred
an intermediate immunity phenotype (turbid halo).
DISCUSSION
In this study we demonstrated that cognate immunity to a large
subset of ColM domain-containing Pseudomonas bacteriocins
is provoked by the poorly conserved transmembrane protein
PmiA, unrelated in sequence and topology to the Cmi protein
providing immunity to colicin M in E. coli. The pmiA gene,
consistently located downstream of pseuM on the same strand,
is rarely annotated (Table S3). Previously, immunity to ColM
domains in Burkholderia burkhocins was equally associated with
a transmembrane protein (BmiA; Ghequire and De Mot, 2015b).
However, since ColM domains from bmiA- and pmiA-associated
bacteriocins constitute phylogenetically distant clades, the
immunity mechanism from these integral membrane proteins
may be different. Further support for the existence of such
evolutionarily distinct lipid II-targeting bacteriocin subsets is
provided by the observation that a minor group of pseudomonad
genes shares a similar immunity gene, as well as a similar
ColM-domain-encoding gene, with Burkholderia. The gene
organization of different ColM domain-hosting bacteriocins
and their (putative) immunity genes is summarized in
Figure 5.
A conserved Asp residue located in a semi-conserved
periplasm-exposed stretch proved not pivotal for the immunity
phenotype of PmiA. Possibly, it is required for structural
integrity or stability of the immunity protein, and structural
analysis can give more insight in this issue. Since the periplasm-
exposed moieties of PmiA likely contribute to immunity, it
was investigated whether cross-immunity between proteins with
different extent of sequence conservation in those regions, may
occur. Since this was found to be the case, even between
PmiAs sharing <40% pairwise amino acid identity, it will be
of future interest to determine which residues or structural
elements actually contribute to the immunity phenotype. This
will render a first indication on how and where the immunity
mechanism to this toxin module may be provoked. Previously,
attempts to co-crystallize colicin M and Cmi to enlighten how
Cmi neutralizes ColM-mediated toxicity proved unsuccessful
(Usón et al., 2012).
From an evolutionary point of view, promiscuous protection
by immunity genes sharing low homology may have far-reaching
consequences toward competitive advantage for producer strains.
It may explain why genome analysis in pseudomonads indicated
that PseuMs are rather rare, as compared to DNase and
RNase bacteriocins (Ghequire and De Mot, 2014). In contrast,
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FIGURE 5 | Schematic gene organizations of ColM domain-containing bacteriocins and (putative) immunity genes (if present). The arrows correspond
with the gene orientations and the color legend describes the indicated domains and type of immunity gene. Predicted immunity genes, based on homology with
characterized immunity factors, are delineated by a dashed line. Species abbreviations are as in Figure 1. Bamb, Burkholderia ambifaria; Bglu, Burkholderia glumae.
immunity to the latter bacteriocins is provided by immunity
proteins forming very specifically high-affinity bacteriocin-
immunity complexes, stabilized by conserved hydrogen bonds
and hydrophobic interactions (Li et al., 2004; Levin et al.,
2009; Meenan et al., 2010; Joshi et al., 2015; Kleanthous et al.,
2016). PseuM bacteriocin production may therefore provide
limited benefit in most environments, and hence result in
lower selection pressure to maintain these bacteriocins in
genomes. In addition to this, genome mining also indicated
that orphan pmiA-like genes occasionally occur in Pseudomonas
genomes, although it remains to be investigated whether
these enable cheating. A similar observation was made
for bmiA genes in Burkholderia (Ghequire and De Mot,
2015b) and S-type pyocin immunity genes (Ghoul et al.,
2015).
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